US regulators approve Wegovy pill for weight loss

0
139

By JONEL ALECCIA
Updated 4:18 PM PST, December 22, 2025

The U.S. Food and Drug Administration building in Silver Spring, Md., Aug. 2, 2018. (AP Photo/Jacquelyn Martin, File)

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The U.S. Food and Drug Administration’s approval handed drugmaker Novo Nordisk an edge over rival Eli Lilly in the race to market an obesity pill. Lilly’s oral drug, orforglipron, is still under review.

Both pills are GLP-1 drugs that work like widely used injectables to mimic a natural hormone that controls appetite and feelings of fullness.

In recent years, Novo Nordisk’s injectable Wegovy and Lilly’s Zepbound have revolutionized obesity treatment globally and in the U.S., where 100 million people have the chronic…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here